ProPhase Labs, Inc. (PRPH): M&A transaction — ProPhase Labs sells Pharmaloz subsidiaries for $2M cash and $10M debt relief

ProPhase Labs, Inc.

JL Projects purchased all shares of Pharmaloz Manufacturing and Pharmaloz Real Estate; transaction closed Jan 16, 2025.
JL Projects provided $2M cash and extinguished $10M of ProPhase's debt; also cancelled $300K accrued interest.
JL Projects assumed $3.3M mortgage, $2M capital leases, and $3M payables; paid down $200K affiliate loan.
ProPhase avoided $3M in upcoming capex and transferred $600K employee overhead to PMI.
Sale includes customary representations and warranties; full agreement filed as Exhibit 2.1.

item 1.01 item 2.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

ProPhase Labs, Inc. completed a disposition involving JL Projects, Inc. (closed 2025-01-16).

Action: disposition
Counterparty: JL Projects, Inc.
Closing: 2025-01-16

Exact text from the filing

The transaction closed concurrently with the execution of the Agreement on January 16, 2025.

View on SEC.gov

31 m&a transactions filed in the last 30 days. Browse all m&a transactions →

ProPhase Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-003425

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.